Trending Now
Seelos Therapeutics Inc. (NASDAQ: SEEL) Receive Japanese Patent for SLS-007 and...
Seelos Therapeutics Inc. (NASDAQ: SEEL) has announced that the Japanese Patent Office has issued the company with a patent titled, “STRUCTURE-BASED PEPTIDE INHIBITORS Of...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Otonomy Inc. (NASDAQ:OTIC) Release Positive Phase 1/2 OTO-313 Clinical Study Results...
Otonomy Inc. (NASDAQ:OTIC) announced positive phase 1/2 top-line results in the OTO-313 study in patients having moderately severe persistent tinnitus. The company also provided...
MAKE IT MODERN
LATEST REVIEWS
Small Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment...
The addiction treatment space has been pummeled along with everything else in the growth side of the stock market so far in...
MAKE IT MODERN
PERFORMANCE TRAINING
Jaguar Health Inc (NASDAQ:JAGX) Posts A Growth Of 186% YoY In Q2 2020 Revenues:...
Jaguar Health Inc (NASDAQ:JAGX) reported revenues of $6.3 million in Q2 2020. Mytesi contributed net revenues of $3.2 million in Q2 2020. The number...
S&P 500 had its worst day in more than a month while the Dow...
The Dow Jones Industrial Average tumbled more than 600 points on Wednesday as investors took profits on some of the strong January...
Why is S&P 500 rallying ?
What caused the market to rally today? Let'take a look. It all started with Futures were up big again this morning. The SPY was...
Stocks for the Bioelectronic Medicine Revolution (NVCR, EMED, ECOR)
Bioelectronic medicine is starting to gain widespread attention after years of skepticism. That skepticism is now being eroded by a growing wave of peer-reviewed...
Will MIRA Pharmaceuticals MIRA Stock Keep Surging further on Promising Preclinical Data for Ketamir-2...
Today, the stock of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) soared, thanks to some exciting news. This Miami-based company, known for being a...






















































